vs

Side-by-side financial comparison of NEOGENOMICS INC (NEO) and PROSPERITY BANCSHARES INC (PB). Click either name above to swap in a different company.

PROSPERITY BANCSHARES INC is the larger business by last-quarter revenue ($367.6M vs $186.7M, roughly 2.0× NEOGENOMICS INC). PROSPERITY BANCSHARES INC runs the higher net margin — 31.6% vs -57.9%, a 89.5% gap on every dollar of revenue. Over the past eight quarters, PROSPERITY BANCSHARES INC's revenue compounded faster (19.2% CAGR vs 6.5%).

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...

NEO vs PB — Head-to-Head

Bigger by revenue
PB
PB
2.0× larger
PB
$367.6M
$186.7M
NEO
Higher net margin
PB
PB
89.5% more per $
PB
31.6%
-57.9%
NEO
Faster 2-yr revenue CAGR
PB
PB
Annualised
PB
19.2%
6.5%
NEO

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
NEO
NEO
PB
PB
Revenue
$186.7M
$367.6M
Net Profit
$-108.0M
$116.3M
Gross Margin
43.3%
Operating Margin
46.9%
Net Margin
-57.9%
31.6%
Revenue YoY
11.1%
Net Profit YoY
42.0%
-10.7%
EPS (diluted)
$-0.13
$1.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NEO
NEO
PB
PB
Q1 26
$186.7M
$367.6M
Q4 25
$190.2M
$275.0M
Q3 25
$187.8M
$273.4M
Q2 25
$181.3M
$267.7M
Q1 25
$168.0M
$265.4M
Q4 24
$172.0M
$267.8M
Q3 24
$167.8M
$261.7M
Q2 24
$164.5M
$258.8M
Net Profit
NEO
NEO
PB
PB
Q1 26
$-108.0M
$116.3M
Q4 25
$139.9M
Q3 25
$-27.1M
$137.6M
Q2 25
$-45.1M
$135.2M
Q1 25
$-25.9M
$130.2M
Q4 24
$130.1M
Q3 24
$-17.7M
$127.3M
Q2 24
$-18.6M
$111.6M
Gross Margin
NEO
NEO
PB
PB
Q1 26
43.3%
Q4 25
43.8%
Q3 25
42.8%
Q2 25
42.6%
Q1 25
43.6%
Q4 24
44.9%
Q3 24
44.6%
Q2 24
44.1%
Operating Margin
NEO
NEO
PB
PB
Q1 26
46.9%
Q4 25
-7.1%
65.1%
Q3 25
-14.4%
64.4%
Q2 25
-26.3%
64.3%
Q1 25
-16.6%
62.7%
Q4 24
-10.7%
62.0%
Q3 24
-12.6%
62.1%
Q2 24
-13.3%
55.2%
Net Margin
NEO
NEO
PB
PB
Q1 26
-57.9%
31.6%
Q4 25
50.9%
Q3 25
-14.4%
50.3%
Q2 25
-24.9%
50.5%
Q1 25
-15.4%
49.1%
Q4 24
48.6%
Q3 24
-10.5%
48.6%
Q2 24
-11.3%
43.1%
EPS (diluted)
NEO
NEO
PB
PB
Q1 26
$-0.13
$1.16
Q4 25
$1.48
Q3 25
$1.45
Q2 25
$1.42
Q1 25
$1.37
Q4 24
$1.36
Q3 24
$1.34
Q2 24
$1.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NEO
NEO
PB
PB
Cash + ST InvestmentsLiquidity on hand
$146.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$828.8M
$8.2B
Total Assets
$1.3B
$43.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NEO
NEO
PB
PB
Q1 26
$146.1M
Q4 25
$159.6M
Q3 25
$164.1M
Q2 25
$154.7M
Q1 25
$346.2M
Q4 24
$367.0M
Q3 24
$362.0M
Q2 24
$355.1M
Total Debt
NEO
NEO
PB
PB
Q1 26
Q4 25
$341.9M
Q3 25
Q2 25
Q1 25
Q4 24
$541.1M
Q3 24
Q2 24
Stockholders' Equity
NEO
NEO
PB
PB
Q1 26
$828.8M
$8.2B
Q4 25
$836.6M
$7.6B
Q3 25
$838.3M
$7.7B
Q2 25
$854.0M
$7.6B
Q1 25
$888.3M
$7.5B
Q4 24
$902.3M
$7.4B
Q3 24
$908.2M
$7.4B
Q2 24
$915.9M
$7.3B
Total Assets
NEO
NEO
PB
PB
Q1 26
$1.3B
$43.6B
Q4 25
$1.4B
$38.5B
Q3 25
$1.4B
$38.3B
Q2 25
$1.4B
$38.4B
Q1 25
$1.6B
$38.8B
Q4 24
$1.6B
$39.6B
Q3 24
$1.6B
$40.1B
Q2 24
$1.6B
$39.8B
Debt / Equity
NEO
NEO
PB
PB
Q1 26
Q4 25
0.41×
Q3 25
Q2 25
Q1 25
Q4 24
0.60×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NEO
NEO
PB
PB
Operating Cash FlowLast quarter
$-8.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NEO
NEO
PB
PB
Q1 26
$-8.1M
Q4 25
$1.3M
$78.3M
Q3 25
$8.9M
$194.8M
Q2 25
$20.3M
$98.2M
Q1 25
$-25.3M
$178.2M
Q4 24
$9.8M
$-205.8M
Q3 24
$9.2M
$274.6M
Q2 24
$13.9M
$216.5M
Free Cash Flow
NEO
NEO
PB
PB
Q1 26
Q4 25
$-6.5M
$68.5M
Q3 25
$570.0K
$185.7M
Q2 25
$14.0M
$91.8M
Q1 25
$-29.8M
$171.1M
Q4 24
$-1.8M
$-210.7M
Q3 24
$-1.6M
$270.2M
Q2 24
$814.0K
$211.8M
FCF Margin
NEO
NEO
PB
PB
Q1 26
Q4 25
-3.4%
24.9%
Q3 25
0.3%
67.9%
Q2 25
7.7%
34.3%
Q1 25
-17.8%
64.5%
Q4 24
-1.0%
-78.7%
Q3 24
-0.9%
103.3%
Q2 24
0.5%
81.8%
Capex Intensity
NEO
NEO
PB
PB
Q1 26
Q4 25
4.1%
3.6%
Q3 25
4.4%
3.3%
Q2 25
3.5%
2.4%
Q1 25
2.7%
2.7%
Q4 24
6.7%
1.8%
Q3 24
6.4%
1.7%
Q2 24
8.0%
1.8%
Cash Conversion
NEO
NEO
PB
PB
Q1 26
Q4 25
0.56×
Q3 25
1.42×
Q2 25
0.73×
Q1 25
1.37×
Q4 24
-1.58×
Q3 24
2.16×
Q2 24
1.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NEO
NEO

Segment breakdown not available.

PB
PB

Net Interest Income$321.1M87%
Noninterest Income$46.5M13%

Related Comparisons